Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis

To assess the efficacy and safety of cinacalcet on secondary hyperparathyroidism in patients with chronic kidney disease, Pubmed, Embase, and the Cochrane Central Register of Controlled Trials were searched until March 2016. Trial sequential analysis (TSA) was conducted to control the risks of type...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guoqi, Liu, Hongyan, Wang, Chengzhi, Ji, Xiaojian, Gu, Weijun, Mu, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814442/
https://www.ncbi.nlm.nih.gov/pubmed/29449603
http://dx.doi.org/10.1038/s41598-018-21397-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814442/
https://www.ncbi.nlm.nih.gov/pubmed/29449603
http://dx.doi.org/10.1038/s41598-018-21397-8

Ejemplares similares